Literature DB >> 3959906

Adrenal imaging with technetium-99m-labelled low density lipoproteins.

J L Isaacsohn, A M Lees, R S Lees, H W Strauss, M Barlai-Kovach, T J Moore.   

Abstract

Evaluation of adrenal cortical function by external imaging is currently accomplished by injection of radiolabelled analogs of cholesterol. Although the adrenals do utilized exogenous cholesterol for steroid hormone synthesis, the cholesterol is delivered to the glands not as free cholesterol but through the uptake of low density lipoproteins (LDL), which are subsequently degraded within the adrenal cortical cells to provide cholesterol. Thus, we sought to assess the use of 99mTc-labelled LDL injected into rabbits to obtain external images of the adrenal glands. Adrenal images of all nine rabbits tested were obtained within 18 to 21 hours after injection of 99mTc-LDL. Seven of the rabbits were subjected to adrenal cortical suppression with dexamethasone and then all nine rabbits were imaged a second time. In the untreated animals, visualization of the adrenal glands was accompanied by normal serum cortisol concentrations and accumulation of radiolabel in the adrenals, whereas in the dexamethasone-treated animals, lack of visualization of the adrenal glands was correlated with low serum cortisols, and greatly decreased accumulation of the radionuclide in the adrenals. These findings demonstrate for the first time that LDL, when labelled with 99mTc, can be used to evaluate adrenal cortical function by external imaging.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959906     DOI: 10.1016/0026-0495(86)90156-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Ian R Corbin; Hui Li; Juan Chen; Sissel Lund-Katz; Rong Zhou; Jerry D Glickson; Gang Zheng
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

2.  Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates.

Authors:  D R Elmaleh; J Narula; J W Babich; A Petrov; A J Fischman; B A Khaw; E Rapaport; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

3.  Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. I. Tracer purification, in vitro and in vivo long-term stability, in vitro validation and biodistribution.

Authors:  T Leitha; M Hermann; M Hüttinger; P Angelberger; R Dudczak
Journal:  Eur J Nucl Med       Date:  1993-08

4.  Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall.

Authors:  I L Shih; R S Lees; M Y Chang; A M Lees
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Receptor-mediated uptake of low-density lipoprotein by B16 melanoma cells in vitro and in vivo in mice.

Authors:  A J Versluis; P J van Geel; H Oppelaar; T J van Berkel; M K Bijsterbosch
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

6.  Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes.

Authors:  A J Versluis; P C Rensen; E T Rump; T J Van Berkel; M K Bijsterbosch
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.